Publications by authors named "Sofia Rimondi"
Vet Comp Oncol
March 2024
Article Synopsis
- Capecitabine is an oral medication used to treat various malignant epithelial cancers in humans, but its effects in dogs have been less studied.
- In a retrospective study, 25 dogs with advanced cancers received capecitabine, showing that 68% experienced mild gastrointestinal toxicity, with most cases resolving on their own.
- Of the dogs treated, 13.6% achieved partial remission, and 72.7% maintained stability, indicating an overall clinical benefit rate of 86.4%, suggesting capecitabine could be a promising treatment option for canine cancers.
